ACR Management of Kawasaki Disease Guideline Summary - Guideline Central

Design and created by Guideline Central in participation with the American College of Rheumatology.

Document Overview

Document Title: Management of Kawasaki Disease

Authoring Society: American College of Rheumatology

Document Publication Date: Mar 5, 2022

Page Last Reviewed/Updated: May 5, 2026

Document Type: Guideline

Country of Publication: United States

Full Text Freely Available: Yes

Full Text Guideline: acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24838

Source Citation: Gorelik M, Chung SA, Ardalan K, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. Arthritis & Rheumatology, 2022 Mar 8. doi: 10.1002/art.42041. Epub ahead of print.

Supplemental Implementation Resources

Spanish Translation

Document Scope, Criteria, and Use Cases

Scope: Diagnosis, Management, Treatment

Diseases/Conditions (MeSH)

D056653 - Rheumatoid Vasculitis

D056653 - Rheumatoid Vasculitis

Keywords: Kawasaki disease, diagnostic testing, management, treatment

Target Patient Population: pediatric patients with Kawasaki Disease

Inclusion Criteria: Male, Female, Adolescent, Child, Infant

Health Care Settings: Ambulatory

Intended Users: Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resources: Evidence Tables Project Plan

Number of Source Documents: 62

Includes peer/external review process?: Yes

Includes public comment process?: Yes

Methodologist involvement?: Yes

Patient involvement?: No

Includes multi-disciplinary group?: Yes

Includes systematic review?: Yes

Grades quality of strength of evidence?: Yes

Grades quality of strength of recommendation?: Yes

Discloses funding source?: Yes

Discloses conflicts of interest?: Yes

Includes benefits/harms analysis with recommendations?: Yes